Cargando…

Stereotactic MR-Guided Online Adaptive Radiation Therapy (SMART) for Ultracentral Thorax Malignancies: Results of a Phase 1 Trial

PURPOSE: Stereotactic body radiation therapy (SBRT) is an effective treatment for oligometastatic or unresectable primary malignancies, although target proximity to organs at risk (OARs) within the ultracentral thorax (UCT) limits safe delivery of an ablative dose. Stereotactic magnetic resonance (M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Henke, Lauren E., Olsen, Jeffrey R., Contreras, Jessika A., Curcuru, Austen, DeWees, Todd A., Green, Olga L., Michalski, Jeff, Mutic, Sasa, Roach, Michael C., Bradley, Jeffrey D., Parikh, Parag J., Kashani, Rojano, Robinson, Clifford G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Thoracic Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349650/ https://www.ncbi.nlm.nih.gov/pubmed/30706029 http://dx.doi.org/10.1016/j.adro.2018.10.003

Ejemplares similares

Stereotactic body radiotherapy (SBRT) for central and ultracentral node-negative lung tumors
por: Owen, Dawn, et al.
Publicado: (2020)

Two-and-a-half-year clinical experience with the world's first magnetic resonance image guided radiation therapy system
por: Fischer-Valuck, Benjamin W., et al.
Publicado: (2017)

A Pictorial Review of Radiologic Findings of Foreign Bodies in the Thorax
Publicado: (2022)

Prospective In Silico Evaluation of Cone-Beam Computed Tomography-Guided StereoTactic Adaptive Radiation Therapy (CT-STAR) for the Ablative Treatment of Ultracentral Thoracic Disease
por: Schiff, Joshua P., et al.
Publicado: (2023)

Progression of Pulmonary Function and Correlation with Survival Following Stereotactic Body Radiotherapy of Central and Ultracentral Lung Tumors
por: Regnery, Sebastian, et al.
Publicado: (2020)

Stereotactic ablative radiotherapy of 60 Gy in eight fractions is safe for ultracentral non‐small cell lung cancer
por: Yang, Dan, et al.
Publicado: (2020)

Spatially fractionated stereotactic body radiation therapy (Lattice) for large tumors
por: Duriseti, Sai, et al.
Publicado: (2021)

Dose-response relationship of stereotactic body radiotherapy for ultracentral tumor and comparison of efficacy with central tumor: a meta-analysis
por: Rim, Chai Hong, et al.
Publicado: (2020)

A method to reconstruct and apply 3D primary fluence for treatment delivery verification
por: Liu, Shi, et al.
Publicado: (2016)

MRI quality control for low‐field MR‐IGRT systems: Lessons learned
por: Michael Gach, H., et al.
Publicado: (2019)

Outcomes of stereotactic body radiotherapy 60 Gy in 8 fractions when prioritizing organs at risk for central and ultracentral lung tumors
por: Zhao, Yizhou, et al.
Publicado: (2020)

Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3)
por: Regnery, Sebastian, et al.
Publicado: (2022)

Ten fraction hypofractionated stereotactic body radiotherapy for the management of ultracentral lung tumors: a retrospective analysis of dosimetry, outcomes, and toxicity
por: Rock, Crosby, et al.
Publicado: (2023)

An optimal dose‐fractionation for stereotactic body radiotherapy in peripherally, centrally and ultracentrally located early‐stage non‐small lung cancer
por: Zarębska, Izabela, et al.
Publicado: (2023)

Magnetic Resonance-Guided Stereotactic Body Radiation Therapy/Hypofractionated Radiation therapy for Metastatic and Primary Central and Ultracentral Lung Lesions
por: Sandoval, Maria L., et al.
Publicado: (2023)

Stereotactic body radiation therapy for the treatment of early-stage minimally invasive adenocarcinoma or adenocarcnioma in situ (formerly bronchioloalveolar carcinoma): a patterns of failure analysis
por: Badiyan, Shahed N, et al.
Publicado: (2013)

A Multi-Institutional Experience of MR-Guided Liver Stereotactic Body Radiation Therapy
por: Rosenberg, Stephen A., et al.
Publicado: (2018)

External validation of pulmonary radiotherapy toxicity models for ultracentral lung tumors
por: Chen, Ishita, et al.
Publicado: (2022)

Simulating the Potential of Model-Based Individualized Prescriptions for Ultracentral Lung Tumors
por: Chen, Ishita, et al.
Publicado: (2023)

A Non-Fatal Impalement Injury to the Right Thorax: A Case Report
por: Mann, Adam J, et al.
Publicado: (2023)

Exceeding Radiation Dose to Volume Parameters for the Proximal Airways with Stereotactic Body Radiation Therapy Is More Likely for Ultracentral Lung Tumors and Associated with Worse Outcome
por: Farrugia, Mark, et al.
Publicado: (2021)

Early Outcomes of Patients With Locally Advanced Non-small Cell Lung Cancer Treated With Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiation Therapy: The Mayo Clinic Experience
por: Yu, Nathan Y., et al.
Publicado: (2019)

Practical Implications of Ferromagnetic Artifacts in Low-field MRI-guided Radiotherapy
por: Green, Olga, et al.
Publicado: (2018)

Interobserver reliability in describing radiographic lung changes after stereotactic body radiation therapy
por: Kalman, Noah S., et al.
Publicado: (2018)

Metastasectomy or Stereotactic Body Radiation Therapy With or Without Systemic Therapy for Oligometastatic Esophagogastric Cancer
por: Kroese, Tiuri E., et al.
Publicado: (2022)

Intravascular Placement of Metallic Coils as Lung Tumor Markers for CyberKnife Stereotactic Radiation Therapy
por: Karaman, Kutlay, et al.
Publicado: (2015)

Quantitative FDG-PET/CT predicts local recurrence and survival for squamous cell carcinoma of the anus
por: Cardenas, Michael L., et al.
Publicado: (2017)

A software tool to automatically assure and report daily treatment deliveries by a cobalt‐60 radiation therapy device
por: Yang, Deshan, et al.
Publicado: (2016)

Vesicle biomechanics in a time-varying magnetic field
por: Ye, Hui, et al.
Publicado: (2015)

Intensity modulated radiation therapy and surgery for Management of Retroperitoneal Sarcomas: a single-institution experience
por: Cosper, Pippa F., et al.
Publicado: (2017)

The Role of MRI-Guided Radiation Therapy for Palliation of Mobile Abdominal Cancers: A Report of Two Cases
por: Green, Olga L., et al.
Publicado: (2021)

Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy
por: Youssef, Fady F., et al.
Publicado: (2016)

Brachial plexopathy after stereotactic body radiation therapy for apical lung cancer: Dosimetric analysis and preliminary clinical outcomes
por: Sood, Sumit S., et al.
Publicado: (2017)

Outpatient Anesthesia Facilitates Stereotactic Body Radiation Therapy for Early Stage Lung Cancer Patients With Advanced Cognitive Impairments
por: Gandhidasan, Senthilkumar, et al.
Publicado: (2019)

First Reported Case of Pediatric Radiation Treatment With Magnetic Resonance Image Guided Radiation Therapy
por: Henke, Lauren E., et al.
Publicado: (2019)

Thorax
por: Rokitansky, Alexander
Publicado: (2009)

Thorax
por: Mettler, Fred A., et al.
Publicado: (2006)

Modeling the COVID Pandemic: Do Delays in Surgery Justify Using Stereotactic Radiation to Treat Low-Risk Early Stage Non–Small Cell Lung Cancer?
por: Cao, Lifen, et al.
Publicado: (2023)

Intracranial Stereotactic Radiation Therapy With a Jawless Ring Gantry Linear Accelerator Equipped With New Dual Layer Multileaf Collimator
por: Knutson, Nels C., et al.
Publicado: (2020)

Increases in Serial Pretreatment (18)F-FDG PET-CT Metrics Predict Survival in Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy
por: Prionas, Nicolas D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_iladfnhvhrloa68krqn77e7kp6